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r e s o u r c e
Infections have shaped the human immune system 1,2 , with genetic variability contributing to differential susceptibility to infections 3, 4 . However, a specific genetic variant that may confer protection against one infection could prove to be deleterious for responses to other infections, and this is determined by the local infection burden in different geographical locations 2 . Moreover, the shaping of the immune system by infections also has direct consequences for susceptibility to autoimmune and inflammatory diseases [5] [6] [7] . Unravelling the interactions between environmental factors, such as infections, and the genetic variation in a population is crucial for understanding the pathogenesis of common autoimmune and infectious diseases, and for designing new therapeutic strategies.
The study of healthy population-based cohorts in the context of appropriate microbial stimulations can be used to assess interindividual variability and to identify genetic loci that regulate immune responses [8] [9] [10] [11] [12] . However, practically all of the genome-wide studies done to date have emphasized the regulatory effect of genetic variation on gene expression by focusing on mRNA transcript abundance [8] [9] [10] [11] [12] . Given that protein quantities are more precise regulators of cellular phenotypes 13 , characterizing the genetic loci that regulate protein abundances and biological processes is a crucial next step toward mechanistic insights 14 .
We stimulated peripheral blood mononuclear cells (PBMCs), rather than isolated immune cell populations, to capture interactions between different immune cell types (for example, between monocytes and T cells) that are very important for natural immune responses. We studied inter-individual and inter-stimulus variation in production of cytokines, and we identified independent genome-wide significant cytokine quantitative trait loci (cQTLs). The functional effects of these cQTLs on expression levels of cis-genes were characterized by performing the expression QTL (eQTL) using stimulation-specific expression data 15 . By comparing the bacteria-and fungi-induced cytokine profiles and cQTLs, we found that the genetic variability in the immune genes and pathways is organized around a physiological response to specific pathogens, rather than to a response aiming to modulate production of a specific cytokine. In addition, we identified and validated a cytokine QTL that revealed a trans-regulatory network in the context of cytokine responses to important human pathogens.
RESULTS

Stimulation increases inter-individual variability in cytokine levels
To systematically determine the effect of genetic variation on cytokine production, we obtained PBMCs from 197 individuals of European origin from the 200 Functional Genomics (200FG) cohort in the Human Functional Genomics Project (http://www.humanfunctionalgenomics.org) in three different years (Supplementary Table 1 ) and profiled cytokines secreted in response to a variety of bacterial and fungal pathogens (Supplementary Table 2 ). In the first study, we measured seven cytokines that were induced by ten different stimuli in 73 healthy volunteers (year 2009 cohort). After stringent quality control of cytokine distributions (Online Methods), we obtained a total of 62 (cytokine-stimulus pairs) different cytokine measurements (Supplementary Table 3 ). Cytokine production followed a nonGaussian or bimodal distribution, with a few exceptions (Fig. 1a-d) . Individuals exhibited significantly increased inter-individual variability (P < 0.01) in cytokine secretion following stimulation, as compared with basal unstimulated state (Fig. 1e,f and Supplementary Fig. 1) . Our results are similar to two other data sets measured in 2011 and 2013 (Supplementary Fig. 2 ).
Cytokine responses are organized in a pathogen-specific manner It is possible that an individual could be either a high or low responder when considering all cytokines (for example, tumor necrosis factor (TNF)-α, IL-6 and IL-10) produced in response to one microorganism. Alternatively, an individual could be a high or low responder for a particular cytokine in response to stimulation with any type of pathogen. To distinguish between these two possibilities, we performed an unsupervised clustering of the cytokine responses induced by the various pathogens and microbial ligands. Correlations between the levels of various cytokines were found in response to stimulation with a certain pathogen, rather than in a cytokine pathway, and this conclusion was validated by additional analyses in the cohort studies performed in 2011 and 2013 ( Fig. 2a and Supplementary  Figs. 3 and 4) . For example, bacterial-induced (lipopolysaccharide (LPS), Escherichia coli and Mycobacterium tuberculosis (MTB)) cytokines (TNF-α, IL-6 and IL-10) were strongly clustered together and were clearly separated from the fungus-induced (Candida albicans) cytokine cluster (Fig. 2a) .
Interferon (IFN)-γ and IL-17 production were exceptions to this rule; however, the magnitude of IFN-γ or IL-17 production by PBMCs from any individual correlated independently of the identity of the pathogen stimulus (Fig. 2a) . This suggests an important evolutionary role for T helper (T H ) 17 cell responses, which may be a general host defense pathway for both bacteria and fungi. In addition, the differentiation of naive T cells into T H 1 or T H 17 effector lymphocytes was under the control of monocyte-derived cytokines 16 . Thus, a strong or weak monocyte-dependent cytokine production capacity may be associated with strong or weak helper T cell responses. Following pair-wise correlation of cytokines, however, we observed two clusters (Fig. 2b) , with cluster 1 consisting of cytokines mainly produced by monocytes, and cluster 2 consisting of cytokines known to be released e 5 **** **** **** **** **** *** * * ** Figure 1 Inter-individual variability in cytokine production following PBMC stimulation. The length of the box in the box plot is interquartile range (Q3-Q1). The whiskers indicate the range of 1.5 × the length of the box from either end of the box. The equality of variance of cytokine levels before and after stimulation was tested using Levene's test. Asterisks in the box plots depict significance (*P < 0.01, **P < 0.001, ***P < 0.0001, ****P < 0.00001 CT ( production ( Fig. 2b) . Moreover, T H 1 and T H 17 responses did not strongly correlate with each other, although their correlation was somewhat stronger than that between monocyte and lymphocyte responses. This was also consistent when we focused specifically on one type of stimulation. For example, we observed strong correlation between Candida-induced IL-6 and IL-8 and between Candidainduced IL-10 and TNF-α, whereas IL-17 showed poor correlation with any of the other cytokines ( Supplementary Fig. 5a -c). This indicates that one particular individual could be a high responder in terms of one set of cytokines, but a low responder for other cytokines.
Genome-wide cQTL mapping identifies cell-count independent cQTLs
We generated both genotype and cytokine data for 107 individuals (Supplementary Table 1 ) We used the 2013 data set as a discovery cohort to identify genome-wide significant cQTLs, as this cohort contained the largest number of individuals (n = 79). Genotyping was performed using Illumina HumanOmniExpressExome SNP chip and was imputed to obtain genotypes at ~7 million SNPs. We selected ~4 million SNPs that showed a minor allele frequency ≥5% and passed other standard quality filters. The cytokine and genotype data available enabled us to study cQTLs for three stimuli: a Gram-negative stimulus (LPS), a mycobacterium (MTB) and a fungus (C. albicans), which provided 18 measurements (three stimulations × six cytokines; IL-6, IL-8, IL-10, IL1-RA, IL-1β and TNF-α). IFN-γ and IL-17 measurements were not available for the 2013 data set. Following quality check for cytokine distributions, we obtained 17 stimulation-cytokine pairs ( Supplementary Fig. 2 ) for which the data were reliable to correlate with genotypes at ~4 million SNPs. Raw cytokine levels were first log-transformed and then mapped to genotype data using a linear regression model with age and gender as covariates. This analysis revealed six significant cQTLs (P < 5 × 10 −8 ; Supplementary Tables 4  and 5 ). We identified two independent cQTLs for C. albicans-induced IL-6 levels ( Fig. 3a-c) , two independent cQTLs for MTB-induced IL-8 levels ( Fig. 3d-f) , one for C. albicans-induced TNF-α and one for LPS-induced IL-10 levels, whereas no cQTLs were identified for IL-1β and IL-1RA. The total number cQTLs at different thresholds are listed in Supplementary Table 6 . We next tested whether different immune cell counts in PBMC preparations influence the cQTLs. For this, we made use of the FACS assessment in the 500 Functional Genomics study (500FG cohort), in which cell populations were examined in detail (Online Methods), and measured Candida-induced IL-6 and TNF-α levels. First, we analyzed the correlation structure between cell counts and cytokine measurements ( Supplementary Fig. 6 ) and observed weak correlations (mean correlation coefficients across five cell types = 0.062). For example, Candida-induced IL-6 levels in PBMCs showed a weak correlation with monocyte counts, but not with other cell types. We tested the association of Candida-induced cQTLs with cytokine levels in the 500FG cohort after correcting for age, gender and cell counts. Of those three cQTLs tested, SNP rs11141235, which associated with Candida-induced IL-6 levels, showed a clear replication of association (P = 0.017; Supplementary Table 4) even after correction for monocyte cell counts (P = 0.030). In contrast, none of the six cQTLs were directly associated with cell counts (data not shown), suggesting an independent role for genetic variation in regulating cytokine production.
Correlations between cytokine responses are partially genetically determined The clustering of cytokine responses ( Fig. 2) showed correlations of cytokines induced by specific pathogens, as well as distinct clusters separating the monocyte-derived cytokine production from T-cellderived cytokines induced by various stimuli. To assess whether this observation may denote a genetic component, we tested whether strong cQTLs of one pathogen-induced cytokine (P < 1.0 × 10 −5 ) npg r e s o u r c e could also be associated with cytokine levels induced by other pathogens, albeit with nominal significance (P < 0.05). QTLs of IL-10 were more likely to be pathogen specific ( Supplementary  Fig. 7a ), whereas QTLs of other cytokines (IL-6, IL-8 and TNF-α) were more likely to be shared genetic loci that respond to all pathogens ( Supplementary Fig. 7b,c) . We found similar results with different P value thresholds (Supplementary Fig. 8 ). We also found that all six genome-wide association study (GWAS)-significant cQTLs were associated with cytokines induced by other bacterial and fungal stimulations (Fig. 4a) . SNPs affecting fungus-induced IL-6 and IL-8 were also strongly associated with bacteria-induced IL-6 and IL-8 levels, but not with IL-10 and TNF-α (Fig. 4a) . This indicates that the SNPs associated with IL-6 and IL-8 levels are pathogen independent, maybe because these SNPs act on genes and/or proteins that are downstream of pathogen recognition receptors and are therefore shared between pathogens. These results suggest that the correlation between monocyte-derived cytokines (Fig. 2) may be partly genetically determined. The top association for Candidainduced IL-6 at the chr9q21 locus provides an illustrative example for a strong shared cQTL (Fig. 4b,c) , where the minor allele C at SNP rs11141235 was not only associated with lower C. albicans-induced IL-6 production ( Fig. 3b) , but also with LPS-induced (Fig. 4b) and MTB-induced IL-6 production (Fig. 4c) . Notably, the cQTLs identified in the 2013 cohort were all validated in the other cohorts, demonstrating the robustness of the identified associations (Supplementary Fig. 9) .
A cQTL gene GOLM1 on chr9q21 modulates cytokine production To identify the putative causal genes at six significant cQTLs, we tested the expression levels of all genes located within a 500-kb cis-window of the six cQTLs in PBMCs stimulated with different microbial antigens (Fig. 4d) . Genes identified by this differential expression analysis were not cytokine genes, suggesting that the cQTLs that we identified are mainly trans-QTLs of regulatory genes modulating cytokine production.
The top associated cQTL, rs11141235, which is on the chromosome 9q21 region, was associated with Candida-induced IL-6 levels (Fig. 3a) . To identify the causal mechanism at this locus, we generated gene expression data by RNA sequencing in PBMCs from 70 individuals 18 with and without Candida stimulation. We reconfirmed the significant differential expression of GOLM1 in response to Candida stimulation in this larger cohort (Fig. 4e) . Next, we mapped Candida-response eQTL at rs11141235 and at another SNP, rs11141242, in the locus (D′ = 0.95), which is a more frequent polymorphism. The eQTL results revealed that rs11141242 was significantly (P = 0.016) associated with the expression levels of Golgi membrane protein 1 (GOLM1), and the minor allele was associated with lower levels of GOLM1 (Fig. 5a) , with rs11141235 showing a similar trend (Fig. 5b) , suggesting the regulatory role of haplotypes in regulating GOLM1 expression.
GOLM1 cQTL is associated with susceptibility to candidemia GOLM1 encodes a 73-kDa Golgi protein and is upregulated in response to viral infection 19 . We assessed whether genetic variants in the GOLM1 locus could influence susceptibility to disseminated infection with C. albicans in a previously described cohort of 225 European patients with candidemia 20 . Given that the genotype data at rs11141235 was not available from this cohort, we tested another variant, rs7036187, that is in linkage disequilibrium with rs11141235 (D′ = 1) in the GOLM1 locus and found that it was associated with candidemia; the risk allele A was more frequent in cases (P = 0.016, odds ratio = 2.36). To test whether the GOLM1 cQTL affects candidemia through the IL-6 pathway, we built a coexpression network around GOLM1 using gene expression data from PBMCs of 70 healthy volunteers either following Candida stimulation (Fig. 5c) or without stimulation (Supplementary Fig. 10 ). Pathway enrichment analysis on strongly coexpressed genes (r 2 < 0.8) with GOLM1 during Candida stimulation revealed that GOLM1-coexpressed genes were enriched for cytokine production pathways, which suggests that GOLM1 is associated with cytokine signaling (Fig. 5d) . The enrichment of genes for cytokine signaling after stimulation could also be a consequence of the stimulation and not necessarily specific to GOLM1 coexpression. Thus, we tested whether the extent of gene enrichment for IL-6 signaling was specifically linked to GOLM1 following Candida stimulation (Online Methods) when compared with randomly chosen differentially expressed genes in response to Candida stimulation. We found a much stronger enrichment of genes coexpressed with GOLM1 for IL-6 signaling than randomly chosen genes ( Supplementary Fig. 11a,b) . In addition, in patients with candidemia, we also assessed the effects of the rs7036187 polymorphism, a SNP that is associated with susceptibility to disease, on serum IL-6 concentrations. This SNP was associated with circulating IL-6 concentration (Fig. 5e) , and heterozygous AG genotypes were associated with lower levels of IL-6 (P = 0.015), suggesting that the polymorphisms in the GOLM1 locus may influence Candida-induced cytokines and susceptibility to candidemia.
Cytokine QTLs overlap with human-disease-associated SNPs
We tested whether SNPs that were previously associated with human diseases, particularly with infectious diseases, are enriched with cQTLs. We extracted GWAS SNPs from the National Human Genome Research Institute GWAS catalog 21 and binned them into eight categories on the basis of their association with different human phenotypes (Online Methods). Next we identified all cQTLs that were associated with cytokine levels with P < 0.05 (Supplementary Table 6 ) and tested whether these cQTLs are linked to GWAS SNPs or their proxies. We found that 61% of infectious-disease-associated SNPs were also cQTLs, and 43% of immune-mediated diseaseassociated SNPs were also cQTLs (Fig. 5a) . We used height-associated SNPs as background SNPs (or null set of SNPs) to determine whether cQTLs are more often associated with a particular human disease. Given that a large number of genetic loci were associated with height (for example, 19,798 SNPs from 955 loci), we expected to find a considerable proportion of these SNPs to be colocalized with cytokine QTLs just by chance. Indeed, we found that 38.5% of height-associated SNPs were also cQTLs. Thus, we used these height-associated SNPs as a background set to test whether other disease-associated SNPs are overrepresented in cQTLs than in height-associated SNPs. We observed a significant enrichment (P < 9.99 × 10 −8 ) of cQTLs among infectious-disease-associated SNPs. Nearly 60% of heartdisease-associated SNPs were also cQTLs, suggesting a role for cytokine pathways in the pathogenesis of cardiovascular diseases (Fig. 6a) . We found similar results when we selected cQTLs with a different P value (P < 0.01; Supplementary Table 6) threshold ( Supplementary  Fig. 12 ) to test for their enrichment among GWAS SNPs. However, the sensitivity of the enrichment results dropped when we used more stringent P values to call putative cQTLs, as the number of cQTLs available to perform enrichment analysis was reduced.
Furthermore, we tested whether infectious-and autoimmune-disease-associated SNPs are predominantly associated with increased or decreased cytokine production. We observed no significant difference between the numbers of autoimmune disease risk alleles associated with increased or decreased cytokine production ( Supplementary  Fig. 8 ). In contrast, risk alleles of infectious disease SNPs, with the exception of malaria-associated SNPs, were mostly associated with lower cytokine production capacity (Fig. 6b) . These patterns suggest that the genetic alterations associated with autoimmune diseases are correlated with both increased and decreased cytokine production capacity, whereas susceptibility to infections is associated with a lower capacity for cytokine production from monocytes or lymphocytes, depending on the type of infection. Inflammatory bowel disease (IBD) is a chronic immune-mediated disease of the human gastrointestinal tract. We observed a trend in which a high proportion of risk alleles npg r e s o u r c e of IBD-associated SNPs were associated with lower cytokine production capacity (Fig. 6c) , suggesting a potential role for infectious agents in IBD. These results again highlight the importance of response QTLs to understanding complex human diseases.
DISCUSSION
Although several recent studies have investigated immune traits during steady-state conditions [22] [23] [24] or serologic responses to past infections 25 , an important question remains regarding the architecture of the immune response and its relation to genetic variation. Several eQTL studies have addressed this important question using different immune cell populations, either with or without stimulation 8,9,11,12 , but they have two intrinsic limitations: these studies only used stimulation of purified cell populations with purified ligands (with the exception of influenza virus stimulation in one of the studies), and eQTLs only interrogate transcript levels that are known to correlate only partially with protein abundance 13, [26] [27] [28] [29] . Thus, here we addressed the importance of understanding human immune responses to pathogens by assessing the architecture of one of the most important steps in the activation of the immune responsescytokine production.
First, we not only confirmed the non-normal nature of cytokine production distribution of monocyte-derived pro-inflammatory cytokines 30, 31 , but our findings also extend this to T lymphocytederived cytokines. The non-Gaussian or bimodal distribution of cytokine production identified low and high producers, giving scope to the hypothesis that the cytokine synthesis phenotype may have a strong effect on susceptibility to immune-mediated diseases.
Second, the production capacity of various cytokines strongly correlated with cells being stimulated with a specific pathogen, whereas the correlation was poor when comparing bacterial versus fungal stimulation. This observation makes sense from both an evolutionary point of view, as immune responses mainly need to have plasticity to respond to specific infectious pressures in a certain geographic area 2 , and from a biological point of view, as toll-like receptors are the main receptor pathway recognizing bacteria, whereas C-type lectin receptors mainly recognize fungi. Notably, regulation of the pathogen-specific cytokine responses is most likely only partially genetic, as some genetic polymorphisms regulate multiple cytokine responses to a certain pathogen (especially for monocyte-derived production), whereas others regulate the monocyte-derived production of cytokine responses resulting from multiple pathogens (see below). It is therefore likely that nongenetic external factors encountered during one's lifetime also are important for long-term modulation of cytokine responses, and epigenetic regulation may represent one of the molecular substrates for this process 32, 33 .
One notable exception to the rule of pathogen-centric responses is represented by specific lymphocyte responses, such as IL-17 production, which represents a separate, strongly correlated cluster independent of the type of pathogen and may be an important aspect of IL-17 biology. T H 17 responses are crucial for mucosal host defense 34 , and defects in this pathway lead to high susceptibility to both fungal and bacterial pathogens [35] [36] [37] . These data argue that T H 17 responses are a crucial component of host defense against both bacteria and fungi. Third, we identified six genome-wide significant cQTLs that influence cytokine responses: IL-6 and IL-8 identified the highest number of cQTLs, whereas IL-1β and IL-1Ra revealed no cQTLs, suggesting that the immune response can more easily buffer variation in IL-6 and IL-8, whereas the IL-1 pathway is highly conserved. Moreover, cQTLs are trans-QTLs that influence cytokine production indirectly through regulatory loops, consistent with the observation that cytokine responses are organized around regulation of pathogen-specific host responses, rather than toward regulation of specific cytokines. This is consistent with a recent study showing that 90% of causal SNPs tend to occur near binding sites for master regulators of stimulus-dependent gene expression and map to enhancers, which gain histone acetylation 38 . One of the strongest cQTLs that we identified influenced expression of GOLM1 following Candida stimulation, which in turn influenced susceptibility to candidemia. GOLM1 encodes a Golgi phosphoprotein, also referred as GP73, which is known to respond to viral infections 19 . This molecule has also been tested as a useful circulating biomarker for several viral-and non-viral-induced liver diseases 39, 40 , and the serum GOLM1 levels have been shown to correlate with serum IL-6 levels in hepatocellular carcinoma 41 . The trans-regulatory network of GOLM1 that we describe here provides further insights into the understanding of the GOLM1-mediated cytokine regulation, not only in cancer, but also for infectious diseases.
There are also some limitations to our study. First, we cannot exclude the possibility that cQTLs were missed and/or that some of the cQTLs with rare allele frequencies were false positives in the analyses, as a result of the relatively low number of volunteers. These limitations also prevented us from performing a robust assessment of cQTLs of lymphocyte-derived cytokines. Second, we investigated cytokine levels induced by bacterial and fungal pathogens, but not by viral stimuli. Third, variation in the immune system can be driven by both heritable and nonheritable influences. Finally, the experimental setup of ex vivo PBMCs stimulated for 24 h provides the opportunity to study the interactions between immune cells such as monocytes, T cells and B cells in response to pathogens. However, the time-dependent dynamic interactions at the tissue level are only partially captured. Thus, PBMCs alone may not fully provide the in vivo picture of immune response, as cell-cell interactions also occur at specific tissue locations. These questions will need to be addressed in the future.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
Ethics statement. Samples of venous blood were drawn after informed consent was obtained, and the study was approved by the Ethical Committee of Radboud University Nijmegen (nr. 42561.091.12). Experiments were conducted according to the principles expressed in the Declaration of Helsinki.
200FG cohort. Individuals in this study were foresters from the Geldersch Landschap, Hoge Veluwe, Twickel, and Kroondomein het Loo in the Netherlands. Foresters were asked to donate blood to determine the serology against Borrelia bacteria, as Lyme disease occurs as an occupational disease. The cohort of individuals was chosen because of the good health reported by this general population. None of the volunteers included in the study had Borrelia infection. In this cohort, all individuals gave written informed consent to donate extra blood to use for research. Blood was drawn in 2009, 2011 and 2013. The foresters were between 23-73 years old, and consisted of 77% males and 23% females. The cQTLs identified were additionally validated in a cohort of 500 healthy individuals of Dutch European ancestry from the Human Functional genomics Project (500FG cohort, www.humanfunctionalgenomics.org).
PBMC collection and stimulation experiments.
After obtaining informed consent, venous blood was drawn from the cubital vein of volunteers into 10 mL EDTA tubes (Monoject). Isolation of PBMCs was performed according standard protocols, with minor modifications. The PBMC fraction was obtained by density centrifugation of blood diluted 1:1 in pyrogen-free saline over Ficoll-Paque (Pharmacia Biotech). Cells were washed twice in saline and suspended in medium (RPMI 1640) supplemented with gentamicin 10 mg/mL, l-glutamine 10 mM and pyruvate 10 mM. Addition of antibiotics such as gentamycin is a standard methodology used to avoid contamination of cultures, and it does not influence the ability to induce cytokine production by PBMCs or macrophages (data not shown). The cells were counted in a Coulter counter (Coulter Electronics) and the number was adjusted to 5 × 10 6 cells/mL. Then 5 × 10 5 PBMCs in a 100-µL volume were added to round-bottom 96-wells plates (Greiner) and incubated with 100 µL of stimulus. After 24 h the supernatants were collected and stored at −20 °C until assayed. The stimulation time periods were chosen based on extensive previous studies that showed that 24 h stimulation was best suited to assess monocyte-derived cytokines 42, 43 .
Stimulation of PBMCs. Bacteria. Bacteroides fragilis (NCTC 10584) grown anaerobically overnight at 37 °C on blood agar plates (BD Biosciences) was inoculated in 20 mL pre-warmed and pre-reduced Brain Heart Infusion broth (BD Diagnostics) and again grown anaerobically overnight at 37 °C until reaching stationary growth phase mimicking growth conditions in abscesses. Bacterial suspensions were washed three times in phosphatebuffered saline (PBS; B. Braun Medical B.V.) and heat-killed at 95 °C for 30 min. Before heat-killing, aliquots of bacterial suspensions were taken to determine colony-forming unit (cfu) counts. Heat-killed bacteria were washed again and after adjusting the concentration in PBS to 1 × 10 8 cfu/mL, stored at −80 °C. B. fragilis was used in the stimulation experiments as 1 × 10 6 /mL. E. coli ATCC 25922 was grown overnight in culture medium, washed three times with PBS, and heat-killed for 60 min at 80 °C; S. aureus strain ATCC 29213 was grown overnight in culture medium, washed twice with cold PBS, and heat-killed for 30 min at 100 °C; both E. coli and S. aureus were used in a final concentration of 1 × 10 6 /mL. Success of heat-inactivation was confirmed by cultures.
Cultures of H37Rv M. tuberculosis (MTB) were grown to mid-log phase in Middlebrook 7H9 liquid medium (Difco, Becton-Dickinson) supplemented with oleic acid/albumin/dextrose/catalase (OADC) (BBL, Becton-Dickinson), washed three times in sterile saline, heat killed and then disrupted using a bead beater, after which the concentration was measured using a bicinchoninic acid (BCA) assay (Pierce, Thermo Scientific).
Fungi. Heat-killed C. albicans blastoconidia (strain ATCC MYA-3573, UC 820) at a concentration of 106 CFU/mL were used throughout this study. To generate hyphae, live yeast forms of Candida were grown for 24 h at 37 °C in RPMI 1640 (Gibco-BRL), adjusted to pH 6.4 by using hydrochloric acid. After 24 h, more than 95% of blastoconidia were grown to hyphae, which were checked by microscope. Hyphae were heat killed for 45 min at 98 °C and resuspended in RPMI 1640 to a hyphal inoculum size that originated from 10 6 /mL blastoconidia (referred to as 10 6 /mL hyphae).
Ligands, FSL-1 and Pam3Cys, were purchased at EMC microcollections (L-7000, L-2000, respectively) and used in a final concentration of 1 µg/mL and 10 µg/mL.
Microbial ligands. MDP (muramyl dipeptide) was purchased at Sigma (A-9519) and used at a final concentration of 10 µg/mL. LPS (E. coli serotype 055:B5) was purchased from Sigma and an extra purification step was performed as described previously 44 . Purified LPS was tested in Tlr4 −/− mice for the presence of contaminants and did not have any TLR4-independent activity 45 .
A total of 5 × 10 5 PBMCs in a total volume of 200 µL per well were incubated at 37 °C in round-bottom 96-well plates (Greiner) with the different stimuli, as indicated above. After 24 h (early cytokines IL-1β, TNF-α, IL-6, IL-8 and IL-10), or 7 d of incubation (IFN-γ and IL-17), supernatants were collected and stored at −20 °C until assayed. When cells were cultured for 7 d, this was done in the presence of 10% human pooled serum.
Cytokine measurements. Concentrations of human cytokines determined using specific commercial ELISA kits from R&D Systems: IL-1β (catalog number DLB50), IL-6 (D6050), IL-10 (D1000B), TNF-α (DTA00C), IL-17 (D1700), or IFN-γ (DIF50) in accordance with the manufacturers' instructions. Detection limits were 20 pg/mL, except for IFN-γ ELISA (12 pg/mL).
IL-6 measurements in candidemia cohort.
Concentrations of human IL-6 in the serum of candidemia patients were determined using specific commercial ELISA kits (PeliKine Compact or R&D Systems), in accordance with the manufacturers' instructions. The data were available for 117 Caucasian candidemia patients. Candidemia patients were stratified on rs7036187 SNP genotype to obtain 111 AA and 6 AG patients. For each individual the median values of IL-6 levels measured across 15 d were used. The statistical difference was tested using a student t test (one-sided) by comparing the log2 transformed IL-6 values. P < 0.05 was considered to be significant.
Cytokine clustering and variance analysis. Raw cytokine levels were first logtransformed, then cytokine measurements showing little/no variation across individuals were filtered out for the follow-up analysis. We excluded nine cytokine measurements in 2009. The normality test was performed on both raw (Fig. 1a) and log-transformed data (Supplementary Fig. 13 ) using Shapiro-Wilk normality test, respectively. P > 0.05 was used as threshold for normal distribution. Unsupervised hierarchical clustering was performed using Spearman correlation as the measure of similarity. In order to test the equality of variance of cytokine levels before and after stimulation, Levene's test was used.
Genotyping, quality control and imputation. DNA samples of 112 individuals were genotyped using the commercially available SNP chip, Illumina HumanOmniExpressExome-8 v1.0. The genotype calling was performed using Opticall 0.7.0 (ref. 46 ) using the default settings. Four samples with a call rate ≤ 0.99 were excluded from the data set as were variants with a HWE ≤ 0.0001, call rate ≤ 0.99 and MAF ≤ 0.001. Two samples were excluded as potential ethnic outliers identified by multi-dimensional scaling plots of samples merged with 1000 Genome data (Supplementary Fig. 14) . This resulted in a data set of 106 samples containing genotype information of 282,382 variants for further imputation. The strands and variant-identifiers were aligned to the reference Genome of The Netherlands (GoNL) 18 data set using Genotype Harmonizer 47 . The data was phased using SHAPEIT2 v2.r644 (ref. 48 ) using the GoNL as a reference panel. Finally, this data was imputed using IMPUTE2 (ref. 49) with the GoNL as the reference panel 50 . Post imputation provided 7512899 variants. We selected 3959389 SNPs that showed MAF ≥ 5%, INFO score ≥ 0.8 and three samples per genotype for downstream cytokine QTL mapping.
Cytokine QTL mapping. Lack of either DNA or cytokine measurements for 90 individuals sampled in three different years restricted us to obtain both genotype and cytokine data for 107 individuals out of 197 individuals (Supplementary Table 1 ). We used the 2013 data set as a discovery cohort to identify genome-wide npg significant cQTLs, as this cohort had the largest numbers of individuals (n = 79). The 2009 (n = 30) and 2011 data sets (n = 78) were used as validation cohorts. We coded gender information either 0 for females or 1 for males. The actual age and coded gender information were included as co-variables in the linear model to correct the cytokine distributions for QTL mapping. We focused only on infectious stimulations such as LPS, Candida and MTB to map cQTLs, which provided 18 measurements (three stimulations × six cytokines). Given that it was difficult define a numerical cut-off to filter out the cytokine measurements that were not informative, we visually inspected all the cytokine distribution plots to check if the cytokine measurements provide clear variation across individuals (Supplementary Fig. 15) . By manually checking the log-transformed cytokine distributions, we excluded one measurement (MTB-induced TNF-α) from further QTL mapping as this cytokine measurement showed very little variation (low production capacity in the majority of individuals), and was thus not informative (Supplementary Fig. 2 ). Raw cytokine levels were first logtransformed then mapped to genotype data using a linear regression model with age and gender as covariates. P < 5 × 10 −8 was considered to be the threshold for significant cytokine QTLs. To check whether our QTL mapping indicated any significant inflation of test statistics due to population structure, we calculated genetic inflation factor lambda (observed vs. expected P values) for all cytokine measurements. We found that the lambda values were around 1 (0.99-1.04) indicating there is no or very little population stratification ( Supplementary  Fig. 16 ). Given that the different amounts of cytokine production can also be driven by different immune cell counts in PBMC preparations, we tested whether cQTLs can influence the cytokine levels independent of different cell counts. For this, we focused on Candida-induced cQTLs and made use of the FACS assessment in the 500 Functional Genomics study (500FG cohort), in which cell populations are examined in detail. We obtained cell count data measured by FACS for total lymphocytes, T cells, B cells, monocytes and NK cells from 487 individuals from the 500FG cohort. We measured IL-6 and TNF-α levels in response to Candida stimulation to check if the Candida-induced cQTLs can be replicated after cell counts correction.
RNA sequencing and expression analysis. Candidate genes from significant cytokine QTL loci were further tested if they responded to any of the pathogens using RNA seq data from PBMCs of eight individuals, which were stimulated by Pseudomonas aeruginosa, Streptococcus pneumoniae, Mycobacterium tuberculosis, Candida albicans, Aspergillus fumigatus and IL-1α. The PBMCs from 70 individuals of the GONL cohort 18 were stimulated with or without Candida albicans as previously described 51 . Sequencing reads were mapped to the human genome using STAR (version 2.3.0) 52 . The aligner was provided with a file containing junctions from Ensembl GRCh37.71. Htseq-count of the Python package HTSeq (version 0.5.4p3) was used (The HTSeq package, http:// www-huber.embl.de/users/anders/HTSeq/doc/overview.html) to quantify the read counts per gene based on annotation version GRCh37.71, using the default union-counting mode. Differentially expressed genes were identified by statistics analysis using DESeq2 package from bioconductor 53 . The statistically significant threshold (FDR P ≤ 0.05 and fold change ≥ 2) was applied. Gender and age were included as known covariates in a linear model for assessing genotype effect. All eQTL mapping was done using Matrix-eQTL 54 . To build coexpression networks, we extracted top 25 coexpressed genes for top 20 differentially expressed genes in Candida-stimulation experiment and performed the pathway enrichment analysis on these gene-sets. Then, we compared whether these genes are also enriched for IL-6 signaling similar to GOLM1 coexpressed genes (Supplementary Fig. 11a ). In addition, we extracted the coexpressed genes with GOLM1 and ranked them according to their coexpression correlation values with GOLM1. We performed pathway enrichment analysis on top 50 (r 2 with GOLM1 > 0.7), middle 50 (r 2 with GOLM1 between 0.7-0.4), bottom 50 (r 2 with GOLM1 < 0.2) and randomly chosen 50 genes. Then, we tested if the enrichment for IL-6 signaling is dependent on the strength of the coexpression with GOLM1 (Supplementary Fig. 11b ).
Extraction of infectious disease associated SNPs. SNPs associated with a number of infectious diseases that showed P < 9.99 × 10 −6 were extracted using the GWAS catalog (https://www.genome.gov/gwastudies/). As of December 2014, there were two studies on leprosy, two studies on malaria, four studies on tuberculosis, four studies on chronic hepatitis C infection, one study on HPV seropositivity, one study on Dengue shock syndrome and one study on meningococcal susceptibility. By systematic search in the literature, SNPs associated with susceptibility to additional infectious diseases not reported in the GWAS catalog were also extracted. There were three studies on invasive aspergillosis and two studies on pneumococcal disease (Supplementary Table 7) . The infectious disease associated SNPs shown in Figure 6 are rs1519551, rs4833095, rs3132468,  rs9271858, rs16948876, rs3764147, rs11036238, rs9940464, rs6755404, rs958617,  rs6545883, rs1900442, rs8005962, rs1925714, rs4331426, rs2505675, rs160441 , rs1948632, rs6538140 and rs9373523.
GWAS SNP extraction and enrichment analysis. GWAS SNPs from the GWAS catalog 21 and their proxies (r 2 ≥ 0.8 from 500-kb window) were first extracted, which provided a list of SNPs associated to 122 different human traits and diseases. We selected diseases/traits for which at least ten independent SNPs were reported to be associated. We then binned these GWAS SNPs into eight categories based on their association to closely related human phenotypes (cancer, immune-mediated diseases, infectious disease, heart-related traits, blood-related traits, metabolic traits, height and type 2 diabetes related traits). Duplicated SNPs are removed from further analysis. We then intersected the SNPs of each category with cQTLs that showed P < 0.05 in our study. The Fisher exact test was applied to test the over-representation cQTL SNPs in infectious disease SNPs using the height associated SNPs as reference.
Online database. All data used in this project have been catalogued and archived, and are freely available, at BBMRI-NL data infrastructure (http:// hfgp.bbmri.nl/) using the MOLGENIS open source platform for scientific data. This allows flexible data querying and download, including sufficiently rich metadata and interfaces for machine processing (R statistics, REST API) and using FAIR principles to optimize findability, accessibility, interoperability and reusability.
